<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31512144</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1538-2443</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of neurovirology</Title><ISOAbbreviation>J Neurovirol</ISOAbbreviation></Journal><ArticleTitle>Enterovirus A71 capsid protein VP1 increases blood-brain barrier permeability and virus receptor vimentin on the brain endothelial cells.</ArticleTitle><Pagination><StartPage>84</StartPage><EndPage>94</EndPage><MedlinePgn>84-94</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s13365-019-00800-8</ELocationID><Abstract><AbstractText>Enterovirus A71 (EV-A71) is the major cause of severe hand-foot-and-mouth diseases (HFMD), especially encephalitis and other nervous system diseases. EV-A71 capsid protein VP1 mediates virus attachment and is the important virulence factor in the EV-A71pathogenesis. In this study, we explored the roles of VP1 in the permeability of blood-brain barrier (BBB). Sera albumin, Evans blue, and dextran leaked into brain parenchyma of the 1-week-old C57BL/6J mice intracranially injected with VP1 recombinant protein. VP1 also increased the permeability of the brain endothelial cells monolayer, an in vitro BBB model. Tight junction protein claudin-5 was reduced in the brain tissues or brain endothelial cells treated with VP1. In contrast, VP1 increased the expression of virus receptor vimentin, which could be blocked with VP1 neutralization antibody. Vimentin expression in the VP1-treated brain endothelial cells was regulated by TGF-&#x3b2;/Smad-3 and NF-&#x3ba;B signal pathways. Moreover, vimentin over-expression was accompanied with compromised BBB. From these studies, we conclude that EV-A71 virus capsid protein VP1 disrupted BBB and increased virus receptor vimentin, which both may contribute to the virus entrance into brain and EV-A71 CNS infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Wenjing</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Disease, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210029, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Jiandong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210029, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Nan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, People's Hospital of Gaochun, Nanjing, 211300, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Zhixiao</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, People's Hospital of Gaochun, Nanjing, 211300, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Qiyun</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, People's Hospital of Gaochun, Nanjing, 211300, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China. dr-lijun@vip.sina.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Mingshun</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5925-0168</Identifier><AffiliationInfo><Affiliation>Key Lab of Antibody Technique of Health Ministry, Nanjing Medical University, Nanjing, 210016, China. mingshunzhang@njmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology, Nanjing Medical University, Nanjing, 210016, China. mingshunzhang@njmu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Immunology, Nanjing Medical University, Nanjing, 210016, China. xiangbangbang@njmu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>09</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurovirol</MedlineTA><NlmUniqueID>9508123</NlmUniqueID><ISSNLinking>1355-0284</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014746">Vimentin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D037521">Virulence Factors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001812" MajorTopicYN="N">Blood-Brain Barrier</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002199" MajorTopicYN="N">Capillary Permeability</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D036022" MajorTopicYN="N">Capsid Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042783" MajorTopicYN="N">Endothelial Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014746" MajorTopicYN="N">Vimentin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D037521" MajorTopicYN="N">Virulence Factors</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Blood-brain barrier</Keyword><Keyword MajorTopicYN="N">Claduin-5</Keyword><Keyword MajorTopicYN="N">Enterovirus A71</Keyword><Keyword MajorTopicYN="N">VP1</Keyword><Keyword MajorTopicYN="N">Vimentin</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>5</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>9</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31512144</ArticleId><ArticleId IdType="pmc">PMC7040057</ArticleId><ArticleId IdType="doi">10.1007/s13365-019-00800-8</ArticleId><ArticleId IdType="pii">10.1007/s13365-019-00800-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>JoVE Science Education Database . Lab animal research. Compound Administration III. Cambridge: JoVE; 1994.</Citation></Reference><Reference><Citation>Al-Obaidi MMJ, Bahadoran A, Wang SM, Manikam R, Raju CS, Sekaran SD. Disruption of the blood brain barrier is vital property of neurotropic viral infection of the central nervous system. Acta Virol. 2018;62:16&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">29521099</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesten B, Yilmaz A, Hagberg L, Zetterberg H, Nilsson S, Brew BJ, Fuchs D, Price RW, Gisslen M. Blood-brain barrier integrity, intrathecal immunoactivation, and neuronal injury in HIV. Neurol Neuroimmunol Neuroinflamm. 2016;3:e300.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5104266</ArticleId><ArticleId IdType="pubmed">27868081</ArticleId></ArticleIdList></Reference><Reference><Citation>Argaw AT, Gurfein BT, Zhang Y, Zameer A, John GR. VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown. Proc Natl Acad Sci U S A. 2009;106:1977&#x2013;1982.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2644149</ArticleId><ArticleId IdType="pubmed">19174516</ArticleId></ArticleIdList></Reference><Reference><Citation>Banks WA, Farr SA, Morley JE. Permeability of the blood-brain barrier to albumin and insulin in the young and aged SAMP8 mouse. J Gerontol A Biol Sci Med Sci. 2000;55:B601&#x2013;B606.</Citation><ArticleIdList><ArticleId IdType="pubmed">11129390</ArticleId></ArticleIdList></Reference><Reference><Citation>Dallasta LM, Pisarov LA, Esplen JE, Werley JV, Moses AV, Nelson JA, Achim CL. Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am J Pathol. 1999;155:1915&#x2013;1927.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1866950</ArticleId><ArticleId IdType="pubmed">10595922</ArticleId></ArticleIdList></Reference><Reference><Citation>Danielsson Frida, Peterson McKenzie, Caldeira Ara&#xfa;jo Helena, Lautenschl&#xe4;ger Franziska, Gad Annica. Vimentin Diversity in Health and Disease. Cells. 2018;7(10):147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6210396</ArticleId><ArticleId IdType="pubmed">30248895</ArticleId></ArticleIdList></Reference><Reference><Citation>Dave JM, Bayless KJ. Vimentin as an integral regulator of cell adhesion and endothelial sprouting. Microcirculation. 2014;21:333&#x2013;344.</Citation><ArticleIdList><ArticleId IdType="pubmed">24387004</ArticleId></ArticleIdList></Reference><Reference><Citation>Denizot M, Neal JW, Gasque P. Encephalitis due to emerging viruses: CNS innate immunity and potential therapeutic targets. J Inf Secur. 2012;65:1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">22484271</ArticleId></ArticleIdList></Reference><Reference><Citation>Dittmar S, Harms H, Runkler N, Maisner A, Kim KS, Schneider-Schaulies J. Measles virus-induced block of transendothelial migration of T lymphocytes and infection-mediated virus spread across endothelial cell barriers. J Virol. 2008;82:11273&#x2013;11282.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2573263</ArticleId><ArticleId IdType="pubmed">18768959</ArticleId></ArticleIdList></Reference><Reference><Citation>Du N, Cong H, Tian H, Zhang H, Zhang W, Song L, Tien P. Cell surface vimentin is an attachment receptor for enterovirus 71. J Virol. 2014;88:5816&#x2013;5833.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4019121</ArticleId><ArticleId IdType="pubmed">24623428</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng M, Guo S, Fan S, Zeng X, Zhang Y, Liao Y, Wang J, Zhao T, Wang L, Che Y, et al. The preferential infection of astrocytes by enterovirus 71 plays a key role in the viral neurogenic pathogenesis. Front Cell Infect Microbiol. 2016;6:192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5174126</ArticleId><ArticleId IdType="pubmed">28066727</ArticleId></ArticleIdList></Reference><Reference><Citation>Franke WW, Grund C, Kuhn C, Jackson BW, Illmensee K. Formation of cytoskeletal elements during mouse embryogenesis. III. Primary mesenchymal cells and the first appearance of vimentin filaments. Differentiation. 1982;23:43&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">6759279</ArticleId></ArticleIdList></Reference><Reference><Citation>Gladue DP, O&#x2019;Donnell V, Baker-Branstetter R, Holinka LG, Pacheco JM, Fernandez Sainz I, Lu Z, Ambroggio X, Rodriguez L, Borca MV. Foot-and-mouth disease virus modulates cellular vimentin for virus survival. J Virol. 2013;87:6794&#x2013;6803.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3676138</ArticleId><ArticleId IdType="pubmed">23576498</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu YY, Shi K, Yao S, Yang X, Liu YH, Tang L, Dang YW, Chen G, Feng ZB, Pan HB. Morphological characteristics of fatal pediatric hand, foot and mouth disease: a clinicopathological study with related receptors of EV71. Pathol Res Pract. 2017;213:1144&#x2013;1151.</Citation><ArticleIdList><ArticleId IdType="pubmed">28756983</ArticleId></ArticleIdList></Reference><Reference><Citation>Haolong C, Du N, Hongchao T, Yang Y, Wei Z, Hua Z, Wenliang Z, Lei S, Po T. Enterovirus 71 VP1 activates calmodulin-dependent protein kinase II and results in the rearrangement of vimentin in human astrocyte cells. PLoS One. 2013;8:e73900.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3779202</ArticleId><ArticleId IdType="pubmed">24073199</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang SC, Raghavaraju G, Liu HS. High expression of vascular endothelial growth factor in EV71-infected patients does not originate from EV71-infected cells. Intervirology. 2010;53:394&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pubmed">20606461</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y, Zhang C, Wang H, Zhou G, Wang X, Zhang R, Chen S, Ren J, Chen L, Dang D, Zhang P, Xi Y, Wu W, Zhang W, Duan G. Mast cells contribute to enterovirus 71 infection-induced pulmonary edema in neonatal mice. Lab Investig. 2018;98:1039&#x2013;1051.</Citation><ArticleIdList><ArticleId IdType="pubmed">29765110</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanmogne GD, Schall K, Leibhart J, Knipe B, Gendelman HE, Persidsky Y. HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis. J Cereb Blood Flow Metab. 2007;27:123&#x2013;134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2232899</ArticleId><ArticleId IdType="pubmed">16685256</ArticleId></ArticleIdList></Reference><Reference><Citation>Koudelka KJ, Destito G, Plummer EM, Trauger SA, Siuzdak G, Manchester M. Endothelial targeting of cowpea mosaic virus (CPMV) via surface vimentin. PLoS Pathog. 2009;5:e1000417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2670497</ArticleId><ArticleId IdType="pubmed">19412526</ArticleId></ArticleIdList></Reference><Reference><Citation>Kryszke MH, Vicart P. Regulation of the expression of the human vimentin gene: application to cellular immortalization. Pathol Biol (Paris) 1998;46:39&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">9769935</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F, Wang Y, Yu L, Cao S, Wang K, Yuan J, Wang C, Cui M, Fu ZF. Viral infection of the central nervous system and neuroinflammation precede blood-brain barrier disruption during Japanese encephalitis virus infection. J Virol. 2015;89:5602&#x2013;5614.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4442524</ArticleId><ArticleId IdType="pubmed">25762733</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Kong XP, Liu H, Cheng LX, Huang JL, Quan L, Wu FY, Hao B, Liu C, Luo B. Expression of EV71-VP1, PSGL-1 and SCARB2 in tissues of infants with brain stem encephalitis. Fa Yi Xue Za Zhi. 2015;31:97&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pubmed">26245084</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R, Liu L, Mo Z, Wang X, Xia J, Liang Z, Zhang Y, Li Y, Mao Q, Wang J, Jiang L, Dong C, Che Y, Huang T, Jiang Z, Xie Z, Wang L, Liao Y, Liang Y, Nong Y, Liu J, Zhao H, Na R, Guo L, Pu J, Yang E, Sun L, Cui P, Shi H, Wang J, Li Q. An inactivated enterovirus 71 vaccine in healthy children. N Engl J Med. 2014;370:829&#x2013;837.</Citation><ArticleIdList><ArticleId IdType="pubmed">24571755</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T, Ghamloush MM, Aldawood A, Warburton R, Toksoz D, Hill NS, Tang DD, Kayyali US. Modulating endothelial barrier function by targeting vimentin phosphorylation. J Cell Physiol. 2014;229:1484&#x2013;1493.</Citation><ArticleIdList><ArticleId IdType="pubmed">24648251</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosteiro L, Pantoja C, Alcazar N, Marion RM, Chondronasiou D, Rovira M, Fernandez-Marcos PJ, Munoz-Martin M, Blanco-Aparicio C, Pastor J, et al. Tissue damage and senescence provide critical signals for cellular reprogramming in vivo. Science. 2016;354:aaf4445.</Citation><ArticleIdList><ArticleId IdType="pubmed">27884981</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieminen M, Henttinen T, Merinen M, Marttila-Ichihara F, Eriksson JE, Jalkanen S. Vimentin function in lymphocyte adhesion and transcellular migration. Nat Cell Biol. 2006;8:156&#x2013;162.</Citation><ArticleIdList><ArticleId IdType="pubmed">16429129</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med. 2009;15:794&#x2013;797.</Citation><ArticleIdList><ArticleId IdType="pubmed">19543284</ArticleId></ArticleIdList></Reference><Reference><Citation>Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N, Furuse M, Tsukita S. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol. 2003;161:653&#x2013;660.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2172943</ArticleId><ArticleId IdType="pubmed">12743111</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P, Perera R, Yap ML, Cardosa J, Kuhn RJ, Rossmann MG. Structure of human enterovirus 71 in complex with a capsid-binding inhibitor. Proc Natl Acad Sci U S A. 2013;110:5463&#x2013;5467.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3619292</ArticleId><ArticleId IdType="pubmed">23509286</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasti M, Khanbabaei H, Teimoori A. An update on enterovirus 71 infection and interferon type I response. Rev Med Virol. 2019;29:e2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7169063</ArticleId><ArticleId IdType="pubmed">30378208</ArticleId></ArticleIdList></Reference><Reference><Citation>Saunders NR, Dziegielewska KM, Mollgard K, Habgood MD. Markers for blood-brain barrier integrity: how appropriate is Evans blue in the twenty-first century and what are the alternatives? Front Neurosci. 2015;9:385.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4624851</ArticleId><ArticleId IdType="pubmed">26578854</ArticleId></ArticleIdList></Reference><Reference><Citation>Spindler KR, Hsu TH. Viral disruption of the blood-brain barrier. Trends Microbiol. 2012;20:282&#x2013;290.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3367119</ArticleId><ArticleId IdType="pubmed">22564250</ArticleId></ArticleIdList></Reference><Reference><Citation>Tee KK, Lam TT, Chan YF, Bible JM, Kamarulzaman A, Tong CY, Takebe Y, Pybus OG. Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene. J Virol. 2010;84:3339&#x2013;3350.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2838098</ArticleId><ArticleId IdType="pubmed">20089660</ArticleId></ArticleIdList></Reference><Reference><Citation>Tornavaca O, Chia M, Dufton N, Almagro LO, Conway DE, Randi AM, Schwartz MA, Matter K, Balda MS. ZO-1 controls endothelial adherens junctions, cell-cell tension, angiogenesis, and barrier formation. J Cell Biol. 2015;208:821&#x2013;838.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4362456</ArticleId><ArticleId IdType="pubmed">25753039</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang HL, Kuo EY, Lai TW. Vascular delivery of intraperitoneal Evans blue dye into the blood-brain barrier-intact and disrupted rat brains. Neuroreport. 2018;29:924&#x2013;931.</Citation><ArticleIdList><ArticleId IdType="pubmed">29762248</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Diab I, Zhang X, Izmailova ES, Zehner ZE. Stat3 enhances vimentin gene expression by binding to the antisilencer element and interacting with the repressor protein, ZBP-89. Oncogene. 2004;23:168&#x2013;178.</Citation><ArticleIdList><ArticleId IdType="pubmed">14712222</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Zhang X, Salmon M, Lin X, Zehner ZE. TGFbeta1 regulation of vimentin gene expression during differentiation of the C2C12 skeletal myogenic cell line requires Smads, AP-1 and Sp1 family members. Biochim Biophys Acta. 2007;1773:427&#x2013;439.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1855268</ArticleId><ArticleId IdType="pubmed">17270292</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao HS, Xie Q, Zhong JY, Gerald Rukundo B, He XL, Qu YL, Cao H. Effect of vimentin on activation of NLRP3 inflammasome in the brain of mice with EV71 infection. Nan Fang Yi Ke Da Xue Xue Bao. 2018;38:704&#x2013;710.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6765721</ArticleId><ArticleId IdType="pubmed">29997093</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J, Qian Y, Wang S, Serrano JM, Li W, Huang Z, Lu S. EV71: an emerging infectious disease vaccine target in the Far East? Vaccine. 2010;28:3516&#x2013;3521.</Citation><ArticleIdList><ArticleId IdType="pubmed">20304038</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu T, Lin Z, Wang C, Li Y, Xia Y, Zhao M, Hua L, Chen Y, Guo M, Zhu B. Heat shock protein 70 as a supplementary receptor facilitates enterovirus 71 infections in vitro. Microb Pathog. 2019;128:106&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pubmed">30579945</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, Takemura T, Koike S. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med. 2009;15:798&#x2013;801.</Citation><ArticleIdList><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Zou L, Yang Y, Yuan J, Hu Z, Liu H, Peng H, Shang W, Zhang X, Zhu J, Rao X. Superficial vimentin mediates DENV-2 infection of vascular endothelial cells. Sci Rep. 2016;6:38372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5133558</ArticleId><ArticleId IdType="pubmed">27910934</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang SL, Chou YT, Wu CN, Ho MS. Annexin II binds to capsid protein VP1 of enterovirus 71 and enhances viral infectivity. J Virol. 2011;85:11809&#x2013;11820.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3209289</ArticleId><ArticleId IdType="pubmed">21900167</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu YT, Chien SC, Chen IY, Lai CT, Tsay YG, Chang SC, Chang MF. Surface vimentin is critical for the cell entry of SARS-CoV. J Biomed Sci. 2016;23:14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4724099</ArticleId><ArticleId IdType="pubmed">26801988</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu C, Shen H, Zhu L, Zhao F, Shu Y. Plasminogen activator inhibitor 1 promotes immunosuppression in human non-small cell lung cancers by enhancing TGF-beta1 expression in macrophage. Cell Physiol Biochem. 2017;44:2201&#x2013;2211.</Citation><ArticleIdList><ArticleId IdType="pubmed">29253845</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>